AG-13958 是 VEGFR 酪氨酸激酶抑制剂，可用于年龄相关性黄斑变性 (AMD) 的脉络膜新生血管形成的研究。

AG-13958 (AG-013958), a potent VEGFR tyrosine kinase inhibitor, for the treatment of age-related macular degeneration.

319460-94-1

C26H22FN7O

467.508

AG-013958;N-[2-氟-5-[[3-[(1E)-2-(2-吡啶基)乙烯基]-1H-吲唑-6-基]氨基]苯基]-1,3-二甲基-1H-吡唑-5-甲酰胺

DMSO:5 mg/mL (10.70 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years